<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>In the Burkitt <z:hpo ids='HP_0002665'>lymphoma</z:hpo> line Oma-BL1, EBV positive and negative cells coexist </plain></SENT>
<SENT sid="1" pm="."><plain>We demonstrate that EBV positive and negative subclones are identical with respect to chromosome markers and HLA type and that the same c-myc rearrangement occurs in <z:hpo ids='HP_0000001'>all</z:hpo> the subclones </plain></SENT>
<SENT sid="2" pm="."><plain>This shows that the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cells are derived from the same patient and are of monoclonal origin </plain></SENT>
<SENT sid="3" pm="."><plain>In the positive subclones, the EBV genome was stably maintained in the episomal form </plain></SENT>
<SENT sid="4" pm="."><plain>The EBV negative subclones could be derived from previously uncloned <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cells in early passage, but not from the EBV positive subclones </plain></SENT>
</text></document>